Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 2 (RPL12P2)

Target: RPL12P2
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L12 pseudogene 2 (RPL12P2) is a processed pseudogene of the ribosomal protein L12 gene, meaning it resembles the functional gene but does not encode an active protein product. It is listed under NCBI Gene ID 646875 and is also known as dJ441G21.1 and RPL12_6_688. As a pseudogene, RPL12P2 does not have a demonstrated biological function, is not associated with disease, and is not considered a therapeutic target. It is relevant primarily as a genomic element for studies of gene evolution and annotation.

Other names: RPL12_6_688dJ441G21.1

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 2 (RPL12P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 2 (RPL12P2).

Explore the full profile